Clinical trials
According to your needs, we provide imaging CRO services and exploratory biomarker services.
Compliance
About
Resonance Clinical
Fully conversant with the FDA, UKCA, CE and TGA regulatory requirements.
Trusted by
Therapeutic areas
Creating breakthroughs since 2005
Iron overload disorders
Haemochromatosis, thalassaemia, sickle cell disease (SCD), anaemia, myelodysplastic syndrome (MDS), transfusion dependent blood cancers, and bone marrow failure disorders.
Liver related disorders
Alcoholic liver disease, viral hepatitis, liver related toxicity, and hepatocellular carcinoma (HCC).
Metabolic disorders
Cardiovascular disease, obesity, diabetes, non-alcoholic steatohepatitis (NASH).
Brain diseases
Stroke, traumatic brain injuries, Alzheimer’s disease (AD), dementia, Parkinson’s disease (PD), motor neuron disease and multiple sclerosis.
About Resonance Clinical
Your success is based on finding real solutions. We are committed to your success, working with you transparently, proactively, and consistently throughout all phases.
Demonstrated expertise
Our solutions
Imaging CRO services
Resonance Clinical provides quality-assured image analysis services as well as project and data management services. These services support clinical trial customers in meeting trial protocol requirements stipulated by ICH-GCP and international regulatory authorities.
Exploratory biomarker services
From biomarkers to genomics, Resonance Health provides the full spectrum of laboratory analysis services. In addition to our specialised services, we work with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments.